OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC
Executive Summary
US trade regulator will require an "inherent contradiction" for homeopathic OTC labels: disclaimers to FDA-compliant label indications indicating a lack of scientific evidence that the product works.
You may also be interested in...
All About Eye Drops: Warnings To Six Homeopathic And Two Allopathic Firms; Seven US, One Swiss
Common across warnings is all the firms, retailers as well as manufacturers, are marketing OTC eye drops with noncompliant claims, including “prevent or improve cataracts” and “temporarily alleviate blepharitis symptoms.” One also had GMP problems.
GMP Stumble By Contract Manufacturer Trips Up Children’s Homeopathic Product Marketers
Warning letters sent earlier in August note GMP violations for contract manufacturer Denison Pharmaceuticals and customers CalmCo and ALVA-AMCO, which marketed children’s homeopathic products provided by Denison.
FTC Expands Dietary Supplement Advertising Guidance To All Products Making Health-Related Claims
The Federal Trade Commission’s Health Products Compliance Guidance, published 20 December, expands the agency’s focus from dietary supplements to all products making health-related claims, providing the first update in 25 years on the FTC’s thinking on clear and conspicuous disclosures and competent and reliable scientific evidence.